Bcl-11A antibody
Principal name
Bcl-11A antibody
Alternative names for Bcl-11A antibody
BCL11A, CTIP1, EVI9, KIAA1809, B-cell lymphoma/leukemia 11A, B-cell CLL/lymphoma 11A, COUP-TF-interacting protein 1, Ecotropic viral integration site 9 protein homolog
Ncbi ID
9606, NP_075044, NP_060484, NM_022893, NP_060484.2, NP_612569.1, NM_138559, NP_612569, NP_001152761.1, BC010585, NM_016707, NM_001159289, NM_018014
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), Immunoprecipitation (IP), Frozen Sections (C)
Background of Bcl-11A antibody
BCL11A Is a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression.This gene encodes a C2H2 type zinc-finger protein by its similarity to the mouse Bcl11a/Evi9 protein. The corresponding mouse gene is a common site of retroviral integration in myeloid leukemia, and may function as a leukemia disease gene, in part, through its interaction with BCL6. During hematopoietic cell differentiation, this gene is down-regulated. It is possibly involved in lymphoma pathogenesis since translocations associated with B-cell malignancies also deregulates its expression. Multiple transcript variants encoding several different isoforms have been found for this gene.
General readings
Uda,M., (2008) Proc. Natl. Acad. Sci. U.S.A. 105 (5), 1620-1625
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA332690 | Bcl-11A antibody |
||||||
| Rabbit anti-BCL11A Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA590410 | Bcl-11A antibody |
||||||
| Rabbit Polyclonal Ctip1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E |
0.1 mg /
€409.00
|
|
| OriGene Technologies, Inc. | |||||||
| AM31750PU-N | Bcl-11A antibody |
||||||
 |
Mouse | IgG2a | 3D9 | Purified | Hu | E, P, WB |
50 µg /
€475.00
|
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
| AP50355PU-N | Bcl-11A (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
| AP54793PU-N | Bcl-11A (BCL-11A + 11B) antibody |
||||||
 |
Rabbit | Aff - Purified | Hu | C, E, WB |
25 µg /
€460.00
|
||
| OriGene Technologies GmbH | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP323575 | Bcl-11A (transcript variant 3) |
||||
| Recombinant protein of human B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY408578 | BCL11A overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR207799L2V | Lenti ORF particles, Bcl11a (GFP-tagged) - Mouse B-cell CLL/lymphoma 11A (zinc finger protein) (cDNA clone MGC:19371 IMAGE:2631265), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,240.00
|
|
| OriGene Technologies, Inc. | ||
| MR207799L1V | Lenti ORF particles, Bcl11a (Myc-DDK-tagged) - Mouse B-cell CLL/lymphoma 11A (zinc finger protein) (cDNA clone MGC:19371 IMAGE:2631265), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,110.00
|
|
| OriGene Technologies, Inc. | ||
